<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2015.58064</article-id><article-id pub-id-type="publisher-id">OJOG-58520</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Complications of Pregnancy in Patients with Systemic Lupus Erythematosus (Gabon)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>osthène</surname><given-names>Mayi-Tsonga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Landry</surname><given-names>Missounga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Josaphat</surname><given-names>Ibaba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Ronald Edoa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Baptiste Moussavou Kombila</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Internal Medicine, Libreville’s Hospital University, Libreville, Gabon</addr-line></aff><aff id="aff1"><addr-line>Obstetrics Department, Libreville’s Military Hospital, Libreville, Gabon</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>smayi3@yahoo.fr(OM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>07</month><year>2015</year></pub-date><volume>05</volume><issue>08</issue><fpage>443</fpage><lpage>447</lpage><history><date date-type="received"><day>8</day>	<month>June</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>28</month>	<year>July</year>	</date><date date-type="accepted"><day>31</day>	<month>July</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Pregnancy and systemic lupus erythematosus in black African women: about 10 cases in Libreville (Gabon). Objectives: Through a study in a population of systemic lupus erythematosus (SLE) pregnant black Gabonese women, we describe the characteristics of these pregnancies to clarify their main complications and to make recommendations to their follow-up in low resource countries. Patients and Methods: This is a longitudinal descriptive study conducted over a period of six years, from 1 January 2008 to October 31, 2013, in Libreville (Gabon). We’ve included, systemic lupus erythematosus women carrying a pregnancy during the period of the study. Results: Seventy-two SLE women were followed and were eligible. Only 8 patients (11%) were pregnant during the follow up period. These 8 SLE patients allowed us to monitor 10 pregnancies. The average parity was 0.88. Eight pregnancies in ten (80%) had complications and most frequent was preeclampsia. Nine pregnancies (90%) resulted in the birth of viable children of which 4 (44.4%) were born by caesarean section and the 5 others (55.6%) were born by natural route. Conclusion: We recommend a monthly prenatal care for these high-risk pregnancies and early detection of preeclampsia.
 
</p></abstract><kwd-group><kwd>Systemic Lupus Erythematosus</kwd><kwd> Pregnancy</kwd><kwd> Preeclampsia</kwd><kwd> Gabon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The association of systemic lupus erythematosus (SLE) and pregnancy is not well known [<xref ref-type="bibr" rid="scirp.58520-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.58520-ref4">4</xref>] . Pregnancy on SLE field can be a high-risk situation due to the strong involvement of estrogen in the pathogenesis of SLE. Currently, a better understanding of SLE enables more efficient management of these pregnant. The cohorts identified in the literature are exclusively Western while this disease is increasingly diagnosed in black African countries [<xref ref-type="bibr" rid="scirp.58520-ref5">5</xref>] . Through a study in a population of SLE pregnant black Gabonese women, we want to describe the characteristics of these pregnancies to clarify their main complications and to make recommendations as to their follow-up in low resource countries.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This is a longitudinal descriptive study, conducted over a period of six years from 1 January 2008 to 31 October 2013, in departments of infectious diseases at the Libreville University Hospital (LUH) and of obstetrics and gynecology Hospital Army at Libreville (HAL) in Gabon.</p><p>Were included, lupus-known women documented by international standards of the American College of Rheumatology (ACR), carry a pregnancy during the period of the study and followed in both services.</p><p>SLE women followed at LUH are seen on a quarterly in visit. Their clinical and laboratory findings are recorded in individual medical record tracking. Pregnancy is permitted if the lupus activity index (LAI) is less than 4 for at least 6 months, as recommended by the ACR. Above this index, spontaneous occurrence of pregnancy is almost impossible. Only patients with a LAI &lt; 4 were included in the study. Once pregnant, these women are addressed in the obstetrics and gynecology department of the HAL for monitoring pregnancy and childbirth. At each pre natal visit (PNV), in addition to clinical examination, fetal ultrasound coupled with Doppler (uterine artery, umbilical artery) was performed. A cardiological opinion was requested when the blood pressure rose beyond 140/90 mm Hg. The results of these examinations were registered on the clinical records of pre natal monitoring. The data of parturition and postpartum were recorded on individual field.</p><p>For each patient, we collected the following: sociodemographic characteristics, those of lupus, pregnancy monitoring, delivery and data of the newborn.</p><p>The capture and analysis of data were made on EPI info 6.04. Given the weakness of our sample, our study is a case series with a distribution randomly. Quantitative data were made in averages and qualitative data were described using numbers and percentages.</p></sec><sec id="s3"><title>3. Results</title><p>Seventy-two SLE women were followed in the infectious disease department of LUH and all (100%) were eligible, because with a LAI below 4 for 6 months and being of childbearing age. Only 8 patients (11%) were pregnant during the follow up period. These 8 SLE patients allowed us to monitor 10 pregnancies (2 women were 2 successive pregnancies).</p><p>The average age of patients during pregnancy was 28 years (extremes 21 and 44 years). The mean gravidity was 0.47 gesture with extremes of 0 and 8. The average parity was 0.88 (extremes: 0 and 6), and low pares (n ≤ 2) were the most frequent (87.5%). <xref ref-type="table" rid="table1">Table 1</xref> shows that a history of fetal loss, pre existing on the studied pregnancy was known in 50% of pregnant (n = 4).</p><p>The mean duration of SLE symptoms was 7 years (extremes: 1 and 21). Immunological diagnosis has been established in all cases, with concomitant positive antinuclear antibodies: anti DNA specificity (n = 7), anti</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Personal history of fetal loss</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Term of occurrence (quarter)</th><th align="center" valign="middle" >Number and type of fetal loss (N)</th><th align="center" valign="middle" >Patients (N)</th></tr></thead><tr><td align="center" valign="middle" >First</td><td align="center" valign="middle" >2 SM<sup>*</sup> at 10 WA</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Second</td><td align="center" valign="middle" >1 SM<sup>*</sup> at 18 WA</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Third</td><td align="center" valign="middle" >2 FDIU<sup>**</sup> at 32 WA and 36 WA<sup>***</sup></td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><p><sup>*</sup>SM: Spontaneous miscarriages; <sup>**</sup>FDIU: Fetal death in-utero; <sup>***</sup>WA: week of amenorrhea.</p><p>U1RNP (n = 4) and Sm (n = 1). The dosage of phospholipids antibodies has been practiced by only 4 patients (normal in 3 cases and elevated in 1 case). All 8 patients had received oral corticosteroids gradually decline to a maintenance dose of 10 mg/day; associated with hydroxychloroquine. Three women (37.5%) received an additional immunosuppressive therapy.</p><p>On average, 8 pregnant benefited 3.7 PNV (extremes: 2 and 5) and ultrasound 3.0 (2 and 6). Ultrasound monitoring allowed diagnosing 1 case (12.5%) of intrauterine growth retardation. There were no cases of fetal malformation, and amniotic fluid volume was always normal (100%). The average number of Doppler examinations was 4.3 (extremes: 4 and 5).</p><p>In all cases, the uterine artery Doppler and/or umbilical artery Doppler revealed normal resistance index for the gestational terms. Eight pregnancies in ten (80%) experienced complications and the most frequent was preeclampsia (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>There was 1 case of fetal death in-utero at 23 WA and the 9 other pregnancies (90%) allowed the birth of viable children. The average term of delivery was 33.3 WA (extremes: 32 and 41 WA). There were 3 cases of premature birth with an average term of 35.1 WA (extremes: 32 and 36 WA), and 6 term deliveries (average term: 38.9 WA; extremes: 38 and 41 WA). Four children (4/9 = 33.3%) were born by caesarean section and the other 5 (66.7%) by natural route. The APGAR score at 1 minute averaged 9 (extremes: 9 and 10). The average birth weight was of 2459 g with (extremes: 1430 g and 3860 g). Low fetal birth weight was predominant (n = 5).</p></sec><sec id="s4"><title>4. Discussion</title><p>The data of SLE among pregnant black in sub-Saharan countries remain rare while it is known that the prevalence of lupus in African-Americans and Afro-Caribbean migrants to Europe is six times higher than among native Europeans [<xref ref-type="bibr" rid="scirp.58520-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] .</p><p>It seems that SLE does not affect the fertility of women [<xref ref-type="bibr" rid="scirp.58520-ref8">8</xref>] - [<xref ref-type="bibr" rid="scirp.58520-ref10">10</xref>] . This would explain that our fertility rate of 11% seems similar to the global fertility rate in Gabonese women population in childbearing age, that is 14.3% [<xref ref-type="bibr" rid="scirp.58520-ref11">11</xref>] .</p><p>The age of 28 years in our series can be comparable to that found in the literature [<xref ref-type="bibr" rid="scirp.58520-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref12">12</xref>] . The low gravidity and low parity are usually more common in population of SLE women [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref8">8</xref>] .</p><p>Pregnancy exposes SLE women at risk of lupus flare and spontaneous miscarriages (SM), hence the need for planning the pregnancy. Factors that promote these SM are proteinuria &gt; 500 mg/day, a lupus nephritis underlying, antiphospholipid syndrome, thrombocytopenia and pre existing high blood pressure [<xref ref-type="bibr" rid="scirp.58520-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref14">14</xref>] . The rate of SM is from 8% to 36% [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref14">14</xref>] . All times, in case of occurrence of an unplanned pregnancy, maternal renal function must be carefully monitored [<xref ref-type="bibr" rid="scirp.58520-ref1">1</xref>] . We found a high rate of fetal loss history.</p><p>This rate is declining in western series as being spent these past 40 years from 43% to 17% [<xref ref-type="bibr" rid="scirp.58520-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref13">13</xref>] - [<xref ref-type="bibr" rid="scirp.58520-ref15">15</xref>] , similar to that of the general population of non lupus women which lies between 10% and 15% [<xref ref-type="bibr" rid="scirp.58520-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.58520-ref7">7</xref>] .</p><p>Our average number of PNV seems low and inadequate for monitoring this type of high-risk pregnancies. While the WHO recommends the practice of 4 PNV, but it seems prudent to examine these women at least monthly as proposed by Brandt [<xref ref-type="bibr" rid="scirp.58520-ref9">9</xref>] .</p><p>The use of fetal ultrasound should be systematic at each PNV. On the other hand, Doppler velocimetry revealed no abnormality in our series, which could be linked to good control of lupus disease in pre-conception</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Maternal complications and term of occurrence</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Maternal complications</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >Term of occurrence (WA)</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Severe preeclampsia</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >23, 28 and 34 WA</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >PROM<sup>*</sup></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >33 and 34 WA</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Acute pulmonary edema</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >24 WA</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Pulmonary embolism</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >34 WA</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >FDIU<sup>**</sup></td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >23 WA</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p><sup>*</sup>PROM: premature rupture of ovular membranes; <sup>**</sup>FDIU: Fetal death in-utero.</p><p><sup>*</sup>Corresponding author.</p><p>Preeclampsia is the major complication of these pregnant [<xref ref-type="bibr" rid="scirp.58520-ref13">13</xref>] -[<xref ref-type="bibr" rid="scirp.58520-ref15">15</xref>] . Its frequency varies from 3% to 30% [<xref ref-type="bibr" rid="scirp.58520-ref10">10</xref>] . Our rate of 30% is comparable to that of De Bandt [<xref ref-type="bibr" rid="scirp.58520-ref9">9</xref>] , but the weakness of our sample does not allow extrapolating this result. Prematurity is a common complication with varies from 20% to 54% [<xref ref-type="bibr" rid="scirp.58520-ref2">2</xref>] . Our rate of 40% is consistent with the literature. Regarding the prevalence of low fetal birth weight, the studies are divergent with rates ranging from 10% to 35% [<xref ref-type="bibr" rid="scirp.58520-ref2">2</xref>] .</p><p>Our average length of gestation for preterm infants and full-term pregnancy, seem a little higher than those of Le Thi Huong [<xref ref-type="bibr" rid="scirp.58520-ref17">17</xref>] . This author has found an average period of gestation of 33.3 WA in case of premature birth and 37.4 WA in term delivery. Le Thi Huong [<xref ref-type="bibr" rid="scirp.58520-ref17">17</xref>] found a caesarean section rate of 37%, which is similar to ours.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The association SLE and pregnancy is rare in sub-Saharan literature. We recommend a monthly prenatal care for these high-risk pregnancies and early detection of preeclampsia.</p></sec><sec id="s6"><title>Cite this paper</title><p>Sosth&#232;neMayi-Tsonga,LandryMissounga,JosaphatIbaba,Jean RonaldEdoa,Jean Baptiste MoussavouKombila, (2015) Complications of Pregnancy in Patients with Systemic Lupus Erythematosus (Gabon). Open Journal of Obstetrics and Gynecology,05,443-447. doi: 10.4236/ojog.2015.58064</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.58520-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Waldorf, K.M.A. and Nelson, J.L. (2008) Autoimmune Disease during Pregnancy and the Microchimerism Legacy of Pregnancy. Immunological Investigations, 37, 631-644. http://dx.doi.org/10.1080/08820130802205886</mixed-citation></ref><ref id="scirp.58520-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bae, S.C., Fraser, P. and Liang, M.H. (1998) The Epidemiology of Systemic Lupus Erythematosus in Populations of African Ancestry: A Critical Review of the “Prevalence Gradient Hypothesis”. Arthritis &amp; Rheumatology, 41, 2091-2099. http://dx.doi.org/10.1002/1529-0131(199812)41:12&lt;2091::AID-ART2&gt;3.0.CO;2-D</mixed-citation></ref><ref id="scirp.58520-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Borchers, A.T., Naguwa, S.M. and Carl, L. (2010) The Implications of Autoimmunity and Pregnancy. Journal of Autoimmunity, 34, J287-J299. http://dx.doi.org/10.1016/j.jaut.2009.11.015</mixed-citation></ref><ref id="scirp.58520-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Carvalheiras, G., Vita, P., Marta, S., Trovao, R., Farinha, F., Braga, J., et al. (2010) Pregnancy and Systemic Lupus Erythematosus: Review of Clinical Features and Outcome of 51 Pregnancies at a Single Institution. Clinical Reviews in Allergy &amp; Immunology, 38, 302-306. http://dx.doi.org/10.1007/s12016-009-8161-y</mixed-citation></ref><ref id="scirp.58520-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Clowse, M.E., Magder, L.S., Witter, F. and Petri, M. (2006) Early Risk Factors for Pregnancy Loss in Lupus. Obstetrics &amp; Gynecology, 107, 293-299. http://dx.doi.org/10.1097/01.AOG.0000194205.95870.86</mixed-citation></ref><ref id="scirp.58520-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Cortés-Hernández, J., Ordi-Ros, J. and Paredes, F. (2002) Clinical Predictors of Fetal and Maternal Outcome in Systemic Lupus Erythematosus: A Prospective Study of 103 Pregnancies. Rheumatology, 41, 643-650. http://dx.doi.org/10.1093/rheumatology/41.6.643</mixed-citation></ref><ref id="scirp.58520-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">De Bandt, M. (2005) Lupus et grossesse. Revue de Rhumatisme, 72, 554-562. http://dx.doi.org/10.1016/j.rhum.2004.12.009</mixed-citation></ref><ref id="scirp.58520-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Direction Générale de la Statistique (DGS) et ICF International (2013) Enquête Démographique et de Santédu Gabon II. Calverton, Maryland, et Libreville, Gabon: DGS et ICF International. www.stat-gabon.ga</mixed-citation></ref><ref id="scirp.58520-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Frouchet, M., Gateff, C. and Pineau, J. (1969) Lupus érythémateux aigu disséminé chez l’africain. A propos du premier cas observé au Gabon. Medicine Tropical, 29, 204-207.</mixed-citation></ref><ref id="scirp.58520-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ibaba, J., Nzenzé, J.R. and Biteghé, B. (2011) Profil épidémiologique, diagnostic, thérapeutique et évolutif du lupus systémique en Afrique subsaharienne. Expérience du service de médecine interne du Centre Hospitalier de Libreville: A propos de 37 observations. Médecine d’Afrique Noire, 58, 551-559. www.santetropicale.com</mixed-citation></ref><ref id="scirp.58520-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Le Guern, V., Pannier, E. and Goffinet, F. (2008) Lupus érythémateux systémique et grossesse. La Presse Médicale, 37, 1627-1635. http://dx.doi.org/10.1016/j.lpm.2008.09.001</mixed-citation></ref><ref id="scirp.58520-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Le Thi Huong, D., Wechsler, B. and Piette, J.C. (2002) Kidney, Lupus and Pregnancy. Revue de Médecine Interne, 23, 813-818. http://dx.doi.org/10.1016/S0248-8663(02)00696-3</mixed-citation></ref><ref id="scirp.58520-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Le Thi Huong, D., Wechsler, B. and Piette, J.C. (1994) French Register of Lupus in Pregnancy: The Evaluation. Groupe d’étude sur la grossesse lupique. Revue de Médecine Interne, 15, 305-317.</mixed-citation></ref><ref id="scirp.58520-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Moroni, G. and Ponticelli, C. (2003) The Risk of Pregnancy in Patients with Lupus Nephritis. Journal of Nephrology, 16, 161-167.</mixed-citation></ref><ref id="scirp.58520-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Petri, M. (2005) Review of Classification Criteria for Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America, 31, 245-254. http://dx.doi.org/10.1016/j.rdc.2005.01.009</mixed-citation></ref><ref id="scirp.58520-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Petri, M. and Repke, J. (1991) Frequency of Lupus Flare in Pregnancy. The Hopkins Lupus Pregnancy Center Experience. Arthritis &amp; Rheumatology, 34, 1538-1545. http://dx.doi.org/10.1002/art.1780341210</mixed-citation></ref><ref id="scirp.58520-ref17"><label>17</label><mixed-citation publication-type="book" xlink:type="simple">Robert, Y. (2007) Doppler en obstétrique. In: Robert, Y., Ed., Echographie en pratique obstétricale, Ardens, E Masson, Paris, 102-105.</mixed-citation></ref></ref-list></back></article>